Paul Dioguardi is named as a lobbyist on federal disclosure filings for 18 clients through Forbes-tate. The most recent filing naming them posted in January 2025. Issues reported include Health Issues, Medicare/Medicaid, Budget/Appropriations and Government Issues.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| LYKOS THERAPEUTICS | FORBES-TATE | Q2 2024 | Budget/Appropriations, Veterans, Health Issues |
| CLARITEV (FKA MULTIPLAN CORPORATION) | FORBES-TATE | Q2 2024 | Health Issues |
| INDEPENDENT PHARMACY COOPERATIVE | FORBES-TATE | Q2 2024 | Medicare/Medicaid, Health Issues, Pharmacy |
| GLOBAL MEDICAL RESPONSE | FORBES-TATE | Q2 2024 | Medicare/Medicaid, Labor Issues/Antitrust/Workplace, Transportation |
| CYTOVALE, INC. | FORBES-TATE | Q2 2024 | Medicare/Medicaid, Health Issues |
| VIR BIOTECHNOLOGY, INC. | FORBES-TATE | Q2 2024 | Budget/Appropriations, Health Issues, Government Issues |
| TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION | FORBES-TATE | Q2 2024 | Health Issues |
| MOLINA HEALTHCARE, INC. | FORBES-TATE | Q2 2024 | Health Issues |
| HEALTHY.IO (US), INC. | FORBES-TATE | Q2 2024 | Medicare/Medicaid, Health Issues |
| CONDUENT BUSINESS SERVICES, LLC | FORBES-TATE | Q1 2024 | Medicare/Medicaid |
| ULTRAGENYX PHARMACEUTICAL | FORBES-TATE | Q4 2023 | Health Issues |
| PROCISEDX CORPORATION | FORBES-TATE | Q2 2023 | Health Issues |
| VENATORX PHARMACEUTICALS | FORBES-TATE | Q3 2022 | Health Issues |
| A PLACE FOR MOM, INC. | FORBES-TATE | Q3 2022 | Medicare/Medicaid, Health Issues, Consumer Issues/Safety/Products |
| ALIVECOR, INC. | FORBES-TATE | Q3 2022 | Copyright/Patent/Trademark, Trade (domestic/foreign) |
| SPERO THERAPEUTICS, INC. | FORBES-TATE | Q2 2022 | Health Issues |
| VERDE TECHNOLOGIES | FORBES-TATE | Q1 2022 | Environment/Superfund, Medicare/Medicaid, Law Enforcement/Crime/Criminal Justice |
| STORER TEST EXPRESS DBA BUSTEST EXPRESS | FORBES-TATE | Q1 2022 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2024 | 10 | 1 |
| 2023 | 10 | 1 |
| 2022 | 10 | 1 |
| 2021 | 9 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Paul Dioguardi. See the Capitol Clarity rankings and method.